Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.56 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | CA9 | Q16790 | 4/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6064896 | 0.85 | KMT2A (0.56) | CA12CA1CA2CA9SIGMAR1 | |
| SCHEMBL13518029 | 0.77 | SIGMAR1 (0.49) | CA12CA1CA2CA9SIGMAR1 | |
| SCHEMBL21987081 | 0.76 | CA12 (0.60) | CA12CA1CA2CA9SIGMAR1 | |
| SCHEMBL5282755 | 0.76 | L3MBTL1 (0.47) | CA12CA1CA2CA9MAPT | |
| SCHEMBL3070244 | 0.73 | CA12 (0.69) | CA12CA1CA2CA9SIGMAR1 | |
| SCHEMBL17921774 | 0.73 | L3MBTL1 (0.52) | SIGMAR1MAPTKMT2ALMNAL3MBTL1 | |
| SCHEMBL1908486 | 0.72 | KMT2A (0.61) | MAPTALDH1A1KMT2ALMNAL3MBTL1 | |
| SCHEMBL2739352 | 0.72 | L3MBTL1 (0.48) | SIGMAR1MAPTALDH1A1KMT2ALMNA | |
| SCHEMBL15614451 | 0.72 | LMNA (0.70) | MAPTKMT2ALMNAHPGDMEN1 | |
| SCHEMBL17920550 | 0.72 | L3MBTL1 (0.50) | SIGMAR1MAPTALDH1A1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7030200-B2 | Catalysts for olefin polymerization | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-04-18 | — | — | US | disclosed |
| US-20050245702-A1 | Catalysts for olefin polymerization | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2005-11-03 | — | — | US | disclosed |
| WO-2003076450-A1 | CATALYSTS FOR OLEFIN POLYMERIZATION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245702-A1 | Catalysts for olefin polymerization | PNMT, PPOX, ETFA | CA12 4086/4885CA1 4184/4885CA2 4083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.